PHASE IIA TRIAL OF 1% TOPICAL CIDOFOVIR FOR TREATMENT OF HIGH-GRADE PERIANAL SQU

阶段%20IIA%20试验%20OF%201%%20局部%20西多福韦%20FOR%20治疗%20OF%20高等级%20肛周%20SQU

• 批准号: 8167120
• 负责人: RONALD T. MITSUYASU
• 金额: $ 0.15万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-12-01 至 2010-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8167120
• 关键词: Cidofovir; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; Institution; Intraepithelial Neoplasia; Laboratories; Methods; Patient Self-Report; Phase; Research; Research Personnel; Resources; Safety; Signs and Symptoms; Source; United States National Institutes of Health; diaries; Cidofovir; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; Institution; Intraepithelial Neoplasia; Laboratories; Methods; Patient Self-Report; Phase; Research; Research Personnel; Resources; Safety; Signs and Symptoms; Source; United States National Institutes of Health; diaries

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. To evaluate the safety and tolerability of topical cidofovir in HIV-infected subjects with high-grade perianal squamous intraepithelial neoplasia (perianal HSIL). (method: self-report daily sign & symptom diary, laboratory assessments)

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 评估局部Cidofovir在感染HIV感染的受试者中的安全性和耐受性，具有高级鳞状鳞状上皮内肿瘤（Perianal HSIL）。 （方法：自我报告日常症状和症状日记，实验室评估）